Mustang Bio, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for MBIO, updated each market day.
MBIO AI Sentiment
AI sees no strong directional signal for Mustang Bio, Inc. stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Mustang Bio, Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
Sector
Exchange
Market Cap
$5,630,065
Cap Tier
Employees
4
Headquarters
WALTHAM, MA
Listed Since
Aug. 22, 2017
Website
MBIO Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
MBIO Volatility
Mustang Bio, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
